7.81
-0.05
(-0.64%)
As of 2:57:07 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-109,653.00
-156,324.00
-183,945.00
-192,727.00
-149,683.00
Investing Cash Flow
58,880.00
129,647.00
2,905.00
181,210.00
-117,044.00
Financing Cash Flow
201.00
2,245.00
132,265.00
27,146.00
293,587.00
End Cash Position
41,062.00
67,996.00
92,428.00
141,203.00
125,574.00
Interest Paid Supplemental Data
8,438.00
8,985.00
494.00
--
--
Capital Expenditure
-4,882.00
-10,697.00
-16,349.00
-61,746.00
-18,803.00
Issuance of Capital Stock
--
--
--
--
272,160.00
Issuance of Debt
--
--
124,375.00
--
--
Free Cash Flow
-114,535.00
-167,021.00
-200,294.00
-254,473.00
-168,486.00
12/31/2020 - 6/27/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BEAM Beam Therapeutics Inc.
26.30
-3.59%
FATE Fate Therapeutics, Inc.
1.3150
-4.01%
VERV Verve Therapeutics, Inc.
7.50
+1.15%
NTLA Intellia Therapeutics, Inc.
10.24
-2.62%
CDXS Codexis, Inc.
4.2947
-4.56%
VIR Vir Biotechnology, Inc.
10.27
-0.39%
EDIT Editas Medicine, Inc.
1.3400
-2.20%
ABSI Absci Corporation
3.6950
-3.27%
CRBU Caribou Biosciences, Inc.
1.4550
+11.11%
COGT Cogent Biosciences, Inc.
9.19
-4.47%